Navigation Links
AST Endorses Istanbul Declaration to End Organ Trafficking and Transplant Tourism
Date:8/19/2008

American Society of Transplantation Admonishes Citizens of Rich Nations To

End Reliance on Donors in Less Affluent Nations

MT. LAUREL, N.J., Aug. 19 /PRNewswire/ -- The American Society of Transplantation (AST) endorses The Declaration of Istanbul on Organ Trafficking and Transplant Tourism. The Declaration of Istanbul affirms the principles and practices adopted on May 2, 2008, at an International Summit of more than 150 healthcare professionals, officials, scientists, ethicists and legal scholars from 78 countries and 20 international organizations. Among the members of the Steering Committee are AST members Francis L. Delmonico, M.D., William Harmon, M.D., and Mohamed H. Sayegh, M.D. Dr. Harmon attended the International Summit on Transplant Tourism and Organ Trafficking in May as the AST's representative.

The Declaration aims to combat organ commercialism and to preserve the protection and safety of living organ donors. The message underlying the creation of the Declaration is that the success of transplantation as a life-saving treatment does not require-nor justify-victimizing the world's poor as the source of organs. The Declaration calls for countries to implement programs that will prevent organ failure and to meet the organ needs of its citizens from within its own population.

AST President Barbara Murphy, M.D., stated, "The AST condemns all unethical practices to secure organ donations and strongly encourages countries to adopt practices that ensure dignity and justice in the practice of organ donation."

The Scope of the Problem

With the increasing use of the Internet and the willingness of patients in rich countries to travel and purchase organs, organ trafficking and transplant tourism have become global problems. Vulnerable and marginalized populations such as the poor, illiterate, prisoners, and political refugees in impoverished countries have been enlisted as donors with the promise of compensation, and sometimes against their will.

The Declaration of Istanbul condemns this practice and outlines a number of steps that can help increase organ donation and ensure the protection and safety of living donors.

About AST

The AST is an organization of transplant professionals dedicated to research, education, advocacy and patient care in transplantation science and medicine. The society comprises more than 2,800 transplant physicians, surgeons, scientists and allied health professionals. For more information about AST visit http://www.a-s-t.org.

Contact: Beth Drost

215.884.6499


'/>"/>
SOURCE The American Society of Transplantation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend
2. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
3. Is GMO Food and Organic Food an Either/Or Proposition?
4. Kiwa Bio-Tech Receives Nationally Recognized Organic Products Certification
5. 90 billion tons of microbial organisms live in the deep biosphere
6. Organizational Changes at Silence Therapeutics
7. Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing and the Importance of New Medicare-Related E-Prescribing Legislation
8. Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor
9. Worldwide Clinical Trials Emerges as Leading Global Contract Research Organization
10. Research helps understand factors that influence efficiency of organic-based devices
11. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. ... STACS DNA as a Field Application Specialist. , “I am thrilled that Dr. ... STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings a ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
Breaking Biology Technology:
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)... TURKU, Finland , June 9, 2016 ... French National Police deploy Teleste,s video security solution to ensure ... France during the major tournament ... and data communications systems and services, announced today that its ... Police Prefecture to back up public safety across ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... has awarded the 44 million US Dollar project, ... Security Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... world leader in the production and implementation of Identity Management ... in January, however Decatur was selected ...
Breaking Biology News(10 mins):